This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Gencell Biosystems Limited. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Kevin Daulnay: Innovator in Genomic Analysis
Introduction
Kevin Daulnay is a prominent inventor based in Dublin, Ireland. He has made significant contributions to the field of genomic analysis, particularly through his innovative devices and methods. His work is essential for advancing high-throughput genomic analysis of biological samples.
Latest Patents
Kevin Daulnay holds a patent for a genomic analysis device and methods of use. This patent encompasses a complete genomic analysis device designed for high-throughput genomic analysis of biological samples. His invention is pivotal in enhancing the efficiency and accuracy of genomic studies.
Career Highlights
Kevin is associated with Gencell Biosystems Limited, where he applies his expertise in genomic technologies. His role at the company allows him to contribute to groundbreaking advancements in the field. With a focus on innovation, he continues to push the boundaries of genomic research.
Collaborations
Kevin collaborates with notable colleagues, including Mark Dalton and John Gerard Daly. Their combined efforts foster a dynamic environment for innovation and development in genomic analysis.
Conclusion
Kevin Daulnay is a key figure in the realm of genomic analysis, with a patent that showcases his innovative spirit. His work at Gencell Biosystems Limited and collaborations with esteemed colleagues further solidify his impact on the industry.